LIPOOTCHealthcare · Biotechnology

Lipella Pharmaceuticals Inc.

$0.14-17.56%($-0.03)

TickerSpark Score

64/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIPO research report →

52-Week Range4% of range

Low $0.02

Current $0.14

High $3.17

Companywww.lipella.com

Lipella Pharmaceuticals Inc. , a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus.

CEO: Jonathan Kaufman
IPO: 2022
Employees: 5
HQ: Pittsburgh, PA, US

Price Chart

-95.46% · this period

Valuation

Market Cap: $646.46K
P/E: -0.12
P/S: 3.72
P/B: 0.43
EV/EBITDA: 0.18
Div Yield: 0.00%

Profitability

Gross Margin: -1954.73%
Op Margin: -3115.15%
Net Margin: -3068.97%
ROE: -208.44%
ROIC: -308.84%

Growth & Income

Revenue: $536.36K · 19.29%
Net Income: $-5,016,264 · -8.60%
EPS: $-4.79 · 22.24%
Op Income: $-5,080,542
FCF YoY: -24.84%

Performance & Tape

52W High: $3.17
52W Low: $0.02
50D MA: $0.07
200D MA: $0.32
Beta: 0.84
Avg Volume: 23.14K

Get TickerSpark's AI analysis on LIPO

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Apr 3, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	536,959	$536.96K
Apr 3, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	4,060	$4.06K
Mar 13, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	10,326	$10.33K
Mar 13, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	4,060	$4.06K
Mar 10, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	84,700	$84.70K
Mar 10, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	28,924	$28.92K
Feb 28, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	441,933	$441.93K
Feb 28, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	125,833	$125.83K
Jan 15, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	11,795	$11.79K
Jan 15, 25	Kaufman Jonathan H	director, 10 percent owner, officer: See remarks below.	other	303,041	$303.04K